Liquidia (LQDA) Accounts Payables (2019 - 2026)
Liquidia's (LQDA) quarterly Accounts Payables came in at $11.0 million in Q1 2026, up 26.58% year-on-year from $8.7 million in Q1 2025, and up 198.56% quarter-over-quarter from $3.7 million in Q4 2025.
Liquidia (LQDA) Accounts Payables (2019 - 2026) Analysis & Trends
Liquidia's Accounts Payables history runs 8 years deep, the most recent figure standing at $11.0 million for Q1 2026.
- On a quarterly basis, Accounts Payables rose 26.58% year-over-year to $11.0 million in Q1 2026; TTM through Mar 2026 was $11.0 million, a 26.58% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, down 21.56% from the prior year.
- Accounts Payables grew to $11.0 million in Q1 2026 per LQDA's latest filing, from $3.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $11.3 million in Q2 2025 and bottomed at $841000.0 in Q1 2023.
- The 5-year median for Accounts Payables is $2.3 million (2024), against an average of $4.0 million.
- Across the five-year window, Accounts Payables sank 49.52% in 2023 and jumped 248.39% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $2.2 million in 2022, then tumbled by 36.46% to $1.4 million in 2023, then surged by 235.89% to $4.7 million in 2024, then retreated by 21.56% to $3.7 million in 2025, then jumped by 198.56% to $11.0 million in 2026.
- Per Business Quant, the three latest LQDA Accounts Payables figures stand at $11.0 million (Q1 2026), $3.7 million (Q4 2025), and $6.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 498.30 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 731,000.00 |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Liquidia | 7.47 Bn | 7.25 Bn | 121.79 Mn | 10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.98 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 6.02 Mn |
| Jun 30, 2025 | 11.35 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 841,000.00 |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Jun 30, 2021 | 2.55 Mn |